Methyldopa is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Mylan Pharmaceuticals Inc.. The primary component is Methyldopa.
| Product ID | 0378-0611_5f985660-415a-40e4-a386-a513a1e7b80e |
| NDC | 0378-0611 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Methyldopa |
| Generic Name | Methyldopa |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 1985-04-18 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA070076 |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | METHYLDOPA |
| Active Ingredient Strength | 250 mg/1 |
| Pharm Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 1985-04-18 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA070076 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1985-04-18 |
| Marketing End Date | 2014-03-31 |
| Marketing Category | ANDA |
| Application Number | ANDA070076 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1985-04-18 |
| Ingredient | Strength |
|---|---|
| METHYLDOPA | 250 mg/1 |
| SPL SET ID: | bb1c7c3f-9e6f-4d0e-aea1-6974558659ef |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0378-0421 | Methyldopa | methyldopa |
| 0378-0611 | Methyldopa | methyldopa |
| 16729-030 | Methyldopa | Methyldopa |
| 16729-031 | Methyldopa | Methyldopa |
| 21695-879 | Methyldopa | Methyldopa |
| 21695-880 | Methyldopa | Methyldopa |
| 42254-351 | Methyldopa | Methyldopa |
| 51079-200 | Methyldopa | methyldopa |
| 51079-201 | Methyldopa | methyldopa |
| 62135-321 | Methyldopa | Methyldopa |
| 62135-322 | Methyldopa | Methyldopa |
| 68151-2791 | Methyldopa | Methyldopa |